Global Drug Device Combination Market Size, Share, Forecast Report, 2020-2027

The Global Drug Device Combination is expected to register a CAGR of 11.4% during the forecast period of 2018 to 2023.

In this market, products that comprises of more than two regulated components, i.e., drug and device are considered. Such devices are extensively utilized for therapeutic purposes against diseases like cardiovascular diseases. From the past few years, the global burden of the diseases like cardiovascular diseases, urology diseases, and others have increased. This provided suitable backgrounds for the market to develop and grow. According to the factsheet of 2017 published by the Centers for Disease Control and Prevention it was estimated that ~610,000 people within the U.S. die from heart diseases. Moreover, it is mentionable that from the past few years, the reported cases of urology diseases have increased. According to the cancer research UK, there were ~47,151 new cases of prostate cancer within the region. This is estimated to significantly increase the demand for drug devices for the related therapeutics, enabling the market to grow.

Additionally, factors such as growing healthcare expenditure, rising awareness for the disease, and increasing R&D expenses by the key players drives the global drug device combination market. However, side effects, high cost of the products, and presence of low income countries within the developing regions restricts the market growth. It has been reported that products like Cypher causes thrombosis.
Segmentation:

The Global Drug Device Combination is segmented based on product, application, end user and region.Based on product, the market is segmented into catheter, advanced wound care products, and others. The catheter segment is sub-segmented into antimicrobial catheter, urological catheters, cardiovascular catheters, oximetry catheters, thermodilution catheters, wound drainage catheter, and others. The advanced wound care products segment is sub-divided into antibiotic wound care, bone graft substitutes, antibiotic bone cements, drug eluting stents, photodynamic therapy. The bone graft substitutes segment is sub-segmented into ceramic based bone graft substitute, allograft-based bone graft substitutes, cell-based bone graft substitutes, and others. On the basis of application, the market is devised into coronary angioplasty, tachycardia management, non-cardiovascular treatments, peripheral arterial disease (pad), bone treatment, antimicrobial applications, wound care, ophthalmic treatment, and others. By end user, the market is divided into hospitals & clinics, ambulatory centres, and academic & research organization, and others. In the current scope of the study, the above-mentioned segments are covered into the four global regions, namely- the Americas, Europe, Asia-Pacific and the Middle East & African region.

Key players:
Some of the key players in the global drug device combination are 3M, Abbott Laboratories, AlloSource, Biomet Orthopedics, Inc., Biometrix Medical, Biotronik, Boston Scientific Corporation, C.R. BARD, Inc., Cook Critical Care, Inc., Covidien Ltd, Smith & Nephew Plc, St. Jude Medical Inc, Stryker Corporation, Wright Medical Group, Inc., Zimmer Holding, Inc., and others.

Market Segmentation and Key Market Players

Global Drug Device Combination Market, by Product:

•  Catheter
  • Antimicrobial catheter
  • Urological catheters
  • Cardiovascular catheters
  • Oximetry catheters
  • Thermodilution catheters
  • Wound drainage catheter
  • Others

• Advanced Wound Care Products
  • Antibiotic wound care
  • Bone Graft Substitutes
    •    Ceramic based bone graft substitute
    •    Allograft based bone graft substitutes
    •   Cell based bone graft substitutes
    •   Others
  • Antibiotic Bone Cements
  • Drug Eluting Stents
  • Photodynamic Therapy
  • Others

Global Drug Device Combination Market, by Application:

• Coronary angioplasty
• Tachycardia management
• Non-Cardiovascular Treatments
• Peripheral arterial disease (PAD)
• Bone Treatment
• Antimicrobial Applications
• Wound Care
• Ophthalmic Treatment
• Others

Global Drug Device Combination Market, by End User

• Hospitals & Clinics
• Ambulatory Centres
• Academic & Research Organization